FeesSafety
Pluang+

Bitcoin ETFs see $773M outflows in two days as BTC price hovers near $80,000 support level

Market News
24 Oct 2026
UToday
View Source
Neutral
Bitcoin ETFs see $773M outflows in two days as BTC price hovers near $80,000 support level

U.S. spot Bitcoin ETFs experienced significant outflows totaling $773.43 million over two days, with $137.94 million withdrawn on October 23 alone. Despite this, weekly ETF flows remain positive at around $228.2 million. The outflows coincided with Franklin Templeton receiving Nasdaq approval for two new Bitcoin-focused ETFs that combine U.S. equities exposure with Bitcoin accumulation strategies. Bitcoin's price is testing a key support level near $80,000, with risks of further declines if it breaks below this threshold, especially given elevated leveraged positions that could trigger liquidations. The market shows mixed signals with some support from moving averages but pressure from recent withdrawals and potential forced selling.

Bitcoin ETFs saw $773.43 million in outflows over two days, with $137.94 million withdrawn on October 23 alone, providing context for crypto market activity. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Oct 24, 2026 17:51 WIB: out of 50 major cryptocurrencies, 5 rose and 43 fell. Notable movers include COTI at Rp199 with a 5.38% decline and 84% sell order activity, Litecoin at Rp1,013,979 down 5.24% with 78% sell orders, and Synthetix at Rp3,660 down 5.18% but with 100% buy order activity and a typical hold time of 70 days.

More News

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
34 minutes ago
Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
34 minutes ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
2 hours ago
Apple briefly surpasses Nvidia as world's most valuable company on foldable iPhone launch day

Apple briefly surpasses Nvidia as world's most valuable company on foldable iPhone launch day

Apple's stock hit a record high on the launch day of its foldable iPhone Duo, briefly making it the world's most valuable company with a market cap of about $5.1 trillion, surpassing Nvidia. Despite strong demand and sold-out preorders, limited suppl...

Market News
Bullish
4 hours ago
Senior housing REITs show divided yields amid booming baby boomer demand and operator risks.

Senior housing REITs show divided yields amid booming baby boomer demand and operator risks.

Five senior housing REITs are capitalizing on the aging baby boomer population turning 80, with demand for senior living rising sharply. Welltower and Ventas, focusing on private-pay senior housing, offer lower yields but are priced for growth, while...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App